promaxo-inc

The United States Food and Drug Administration (FDA) has granted Promaxo, Inc. (Promaxo) a 510(k) clearance for its revolutionary office-based MRI system. The 510(k) clearance enables practices and hospitals to accurately and seamlessly guide prostate interventions under the Promaxo scanner. Read More →

. Promaxo’s patient-centric approach will provide patients with cutting-edge technology as it works to expand the frontiers of knowledge in the fields of medical imaging, robotics, and artificial intelligence. Read More →

Promaxo, an Oakland-based medical technology startup developing the portable single-sided MRI, today announced that it has raised the first tranche of Series B-1 funding. The equity round was led by Kineticos Disruptor Fund with participation from existing investors. Launched in 2016, Promaxo plans to revolutionize healthcare with its MR imaging and robotic platform. Read More →

Promaxo, the pioneer in the development of in-office MRI, announced today that it has closed $8M round of financing from a group of super angels and strategic investors. Promaxo will use the funding to accelerate the clinical launch of its... Read More →

LAS VEGAS – July 9, 2019 – PRLog — Amit Vohra was conferred with the “Top 100 Leaders in Health Care” award for his significant contributions towards the health care sector at IFAH 2019, held at Caesars Palace, Vegas on June 18-20, 2019. Promaxo has... Read More →

Medical technology startup Promaxo is excited to announce that it has been selected as a 2019 TiE50 Winner in the prestigious TiE50 Awards Program. This awards competition, now in its tenth year, is a program of TiECon, the world’s largest... Read More →